At JENMED PILLS PRIVATE LIMITED, our robust Research and Development (R&D) capabilities form the cornerstone of our innovative approach to pharmaceutical development.
R&D Strengths:
- Expert team of seasoned R&D professionals
- State-of-the-art infrastructure and equipment
- Focus on new product development
Product Specializations:
We excel in developing semi-finished and finished formulations, including:
- Quality by Design (QbD): We employ QbD methodologies for formula and process optimization.
- Versatile Dosage Forms: Our expertise spans both immediate and modified release dosage forms.
Current Product Focus:
We are currently concentrating our efforts on developing innovative formulations in the following therapeutic categories:
1. Proton Pump Inhibitors
2. Antidepressants
3. Anti-obesity medications
4. Bronchodilators
5. Analgesics and Anti-inflammatory drugs
By combining cutting-edge research with a targeted therapeutic focus, JPPL is positioned at the forefront of pharmaceutical innovation, addressing critical healthcare needs with advanced, high-quality formulations.
